Studies in Biology at University of Bern, Switzerland; PhD on regulation
of alternative splicing at the Karolinska Intitute, Stockholm, Sweden and at Uppsala University, Sweden; Postdoc on post-transcriptional mRNA surveillance at Brandeis University, Boston, USA; research group leader (since 2000) and full professor (since 2010) at the University of Bern, working on mRNA surveillance, turnover and splicing.
Not exact matches
But parts
of each
of four exons in Dscam can become active separately,
at different times — a process called
alternative splicing.
To peel away
at the intricate layers that govern the development
of neurons, a research team led by Chaolin Zhang, PhD, Assistant Professor in Systems Biology and Biochemistry and Molecular Biophysics and Hynek Wichterle, PhD, Associate Professor in Pathology & Cell Biology, Neuroscience, and Neurology,
at the Center for Motor Neuron Biology and Disease, Columbia University Medical Center, focuses on a level
of molecular regulation called
alternative splicing.
The researchers» findings contribute to the mechanistic understanding
of how the machinery required to initiate and propagate action potentials
of neurons are controlled
at the level
of alternative splicing — a very tiny piece
of the neuronal maturation puzzle, but one that has a significant impact.
«Our findings represent the first example
of alternative splicing associated with Bt resistance that evolved in the field,» said Fabrick, who is also an adjunct scientist in the Department
of Entomology
at UA.
Multiple transcripts arising from
alternative initiation or polyadenylation sites, or
alternative RNA
splicing at a single locus were not considered as multiple genes but as variants
of a single transcription unit.
While this phenomenon is known to increase complexity
at the transcriptome level, the effect
of alternative splicing on the complexity
at the proteomic level remains controversial.
«The investigational compounds used in this study represent the first orally available SMN2
splicing modifiers for SMA,» commented Stuart W. Peltz, CEO
of PTC Therapeutics, Inc. «Using the experience and expertise in RNA biology we have gained
at PTC over the last 16 years, we used our
alternative splicing technology to identify and subsequently optimize investigational compounds that target the SMN2
splicing to produce the SMN protein.
psq is a large and complex locus, which, through the use
of three
alternative promoters and
alternative splicing, gives rise to
at least 12 different transcripts (FlyBase; Weber et al. 1995; Horowitz and Berg 1996; Ferres - Marco et al. 2006).